| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Myomo, Inc. (MYO) has 6 insiders with recent SEC Form 4 filings, including 6 buys and 5 sells. MYO is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.28M | $1.64M | - | |
| Dir | 653.9K | $836.9K | +25.0K | |
| CFO | 445.2K | $569.8K | - | |
| Dir | 131.8K | $168.6K | - | |
| Other | 108.6K | $139.0K | -32,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Gudonis Paul R67 | Chief Executive Officer | Buy | 30,000 | $3.22 | $96,612.00 | +2.9% | -67.5% | -71.8% | |
| May 15, 2025 | Kirk Thomas F55 | Director | Buy | 38,767 | $3.25 | $125,992.75 | +6.3% | -67.5% | -71.8% | |
| May 12, 2025 | Kirk Thomas F55 | Director | Buy | 50,000 | $3.35 | $167,500.00 | +19.5% | -47.0% | - | |
| Mar 14, 2025 | Mitchell Micah75 | Chief Commercial Officer | Sell | 48,000 | $5.16 | $247,564.80 | -25.5% | -46.1% | -86.6% | |
| Mar 13, 2025 | Kirk Thomas F55 | Director | Buy | 7,400 | $5.00 | $37,000.00 | +3.0% | -43.6% | -86.3% | |
| Mar 12, 2025 | Kovelman Harry68 | Chief Medical Officer | Sell | 30,000 | $5.50 | $165,018.00 | -23.4% | -47.0% | -87.3% | |
| Sep 5, 2024 | Kovelman Harry68 | Chief Medical Officer | Sell | 6,700 | $3.76 | $25,182.62 | -5.1% | +41.9% | -73.5% | |
| Sep 3, 2024 | Kovelman Harry68 | Chief Medical Officer | Sell | 2,029 | $4.01 | $8,140.35 | -1.5% | +40.9% | -73.5% | |
| May 29, 2024 | Kirk Thomas F55 | Director | Buy | 50,000 | $3.50 | $175,000.00 | +26.8% | +13.8% | -14.9% | |
| May 15, 2024 | Kovelman Harry68 | Chief Medical Officer | Sell | 35,426 | $3.69 | $130,838.85 | -26.5% | +1.3% | -14.6% |